We therefore focused experimental validation on the remaining six genes (MCPH1, PQLC3, TPST2, ALG14, RANGAP1, and KIF21B), whose roles in MM pathogenesis remain uncharacterized. This evidence concerns the gene SLC66A3 and Miyoshi myopathy.